KRAS and neoplasm: Compared to wild type KRAS CRCs, KRAS mutated tumours showed a trend toward female patients (56.3% vs. 43.7%), patients with right-sided tumours (66.7% vs. 33.3%), and a moderately differentiated histology (53.6% vs. 46.4%).